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Abstract 
 
Bone morphogenetic protein 2/4 (BMP2/4), members of the transforming growth 
factor β (Tgf-β) superfamily, play a dichotomous role in the progression of 
cancers through cell growth suppression and the enhancement of tumorigenesis 
in a variety of cancers. Cyclin dependent kinase 8 (CDK8), a protein kinase that 
regulates gene transcription, is involved in a variety of cancers including breast 
and pancreatic cancers as well as in mediating BMP2 signaling via its canonical 
Smad1 pathway. Our studies show that BMP4 induced EMT signals primarily 
though Smad1 and that Yap1, a transcriptional co-activator, is necessary for 
BMP4 induced EMT. Using a highly specific ATP competitive inhibitor of Cdk8 
and its twin kinase Cdk19, Senexin B, we find that blocking the kinase activity of 
Cdk8/19 decreases BMP4 transcription of genes associated with EMT and 
inhibits BMP4 induced invasion. By separately reducing the expression of Cdk8 
and Cdk19, we show for the first time that these kinases have both distinct and 
overlapping functions. Our findings suggest that Cdk8 and Cdk19, along with 
Yap1, are crucial for dictating BMP4/Smad1 responses during EMT and each of 
these factors could serve as a selective therapeutic target to block BMP4 
signaling in cancer progression.  
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Chapter 1 
Introduction 
Epithelial cancer cells from a primary tumor can become metastatic by 
undergoing epithelial to mesenchymal transition (EMT). Activation of EMT is 
characterized by a loss of markers, such as e-cadherin and cell-cell adhesions, 
and a gain in mesenchymal markers, such as the transcriptional markers Snail 
and Slug and changes in the cytoskeletal structure, which can lead to an invasive 
phenotype [1]. EMT induced invasion largely contributes to the advanced 
metastases of cancers [2, 3]. 
Bone morphogenetic proteins 2 and 4 (BMP2/4) share an 83% homology 
in amino acid sequence, and comprise the largest subgroup of the transforming 
growth factor beta (TGF-β) superfamily [4]. The role of TGF-β1 in EMT has been 
widely characterized, however, the role of BMP2/4, particularly BMP4, in EMT 
has been less studied [5]. BMP2/4 canonically signal through the Smad1/5/8 
proteins, which form a complex with the co-Smad, Smad4, that translocate to the 
nucleus to regulate the transcription of target genes [6] [7]. BMP2/4 have also 
been shown to signal independently of the canonical Smad pathway, such as 
through Smad2/3, RhoA/ROCK, TAK1/p38, and PI3-kinase [7-10]. BMPs 
regulate a variety of processes, including differentiation, cell proliferation, and 
EMT during development [7, 11, 12]. The role of BMP4 during cancer 
progression, however, has been paradoxical, given that it can act as both a 
	 2 
tumor suppressor and a tumor promoter [13-16]. In breast cancer, increased 
BMP4 lead to a decrease in metastasis to lung and bone, as well as lower BMP4 
levels have been associated with higher grade cancers [16]. On the other hand, 
BMP4 overexpression can lead to increased cell invasiveness and alterations in 
cell morphology characteristic of EMT in a variety of cancers, including ovarian, 
pancreatic, and colon cancers [13-15].  
Cyclin dependent kinase 8 (Cdk8) is a protein kinase that is part of the 
Mediator complex and regulates gene transcription by its association with RNA 
polymerase II [17]. Cdk8 regulation of gene transcription has a role in tumor 
formation and has been established as an oncogene in various cancers, 
including pancreatic and colon cancers and melanoma [18-20]. Cdk8 has also 
been shown to increase proliferation, growth, and migration in breast cancer [21, 
22]. Cdk8 is involved in agonist-induced linker phosphorylation, and the lack of 
agonist-induced linker phosphorylation has been shown to lead to decreased 
Smad1 transcriptional responses [23]. Despite Cdk8’s emerging role in cancer 
and having a crucial role in Smad1 linker phosphorylation, its role in Smad1 
dependent EMT has yet to be elucidated.  
YAP (Yes-associated protein) is a transcriptional co-activator that 
enhances BMP signaling through its interaction with Smad1 [23, 24]. YAP has 
also been shown to contribute to EMT and promote metastasis in breast and 
colorectal cancer cells [25-27]. Smad1 linker phosphorylation by Cdk8 in the 
nucleus also involves the nuclear translocation of Yap and creates a binding site 
for and recruits Yap to the BMP activated Smad1 [23]. This interaction of Yap 
	 3 
with Smad1 enhances BMP-induced Smad1 gene expression responses of Id1, 
Id2, and Id3 [23].  
During cancer progression, the ECM can become remodeled and result in 
an increase in matrix stiffness [28, 29]. Because cellular function is controlled by 
its physical surroundings, this change in matrix has an effect on cell behavior, 
with a decreased ability to develop stress fibers and a change in gene expression 
[30, 31]. Similarly, cell stiffness is altered during cancer progression. During BMP 
induced EMT, cancer cells decrease in stiffness, leading to increased cell 
invasiveness [32]. Yap activity is affected by matrix rigidity, with a compliant 
matrix resulting in a decrease in Yap nuclear localization and Yap inactivation 
[33]. This link between BMP and YAP could play a crucial role in BMP induced 
EMT on varying substrate stiffness. 
In this study we show that BMP4 induces EMT in ovarian (OvCa429), 
pancreatic (Panc1), and breast (Py2T) cancer cells through the reorganization of 
e-cadherin and actin, the up-regulation of Snail and Slug, and increased 
invasion. Additionally, we show that BMP4 induced EMT is dependent on 
Smad1. We show that EMT and Smad1 localization are both dependent on 
matrix rigidity, with a more compliant matrix resulting in decreased EMT and 
inhibition of Smad1 nuclear localization. We find that BMP4 enhances Yap 
nuclear translocation and Yap enhances Smad1 dependent BMP4 induced EMT 
and invasion. In addition, we find that a compliant matrix inhibits BMP4 induced 
Yap translocation. Moreover, we show that Cdk8/Cdk19 are required for the 
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recruitment of the Smad-Yap interaction and are critical for for BMP4 induced 
EMT and invasion.
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Chapter 2 
Results 
Matrix rigidity and mechanosensitive YAP1 dictate BMP4 induced EMT Smad1 
dependent responses. 
We have recently demonstrated that BMP4 induced EMT alters cell 
stiffness properties and response to mechanical force [32]. To test the effects of 
matrix rigidity on BMP induced EMT, we used three cell line models—OvCa429 
cells, Panc1 cells, and Py2T murine breast cancer cells—that underwent EMT in 
response to BMP4 based on alterations to E-cadherin localization (Figure 2.11A) 
and the actin cytoskeleton (Figure 2.11B), changes in the EMT- transcription 
factors (Figure 2.12C), and increased invasion in response to BMP4 (Figure 
2.12D-E). Using these three cell lines we first examined cellular morphology on 
fibronectin conjugated polyacrylamide gels of elastic modulus 0.5kPa (soft), 8kPa 
(medium) (Methods), or glass (high stiffness). Consistent with prior studies on the 
role of rigidity on cellular phenotypes [34, 35], we find that all three cancer cell 
lines exhibited differences in morphology on the 8kPa (medium) substrate versus 
0.5kPa soft substrates (Figure 2.1 A,B), with cells on the soft substrates being 
rounded and forming clusters, regardless of treatment. Alternatively, cells on the 
stiffer substrates displayed an elongated morphology and were spread out from 
one another upon BMP4 treatment, whereas without treatment the cells were 
closely adhered with
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 a more polygonal-like appearance. Additionally, cells on the substrates 8kPa 
showed similar morphology to cells cultured on plastic and/ or glass (data not 
shown).  
To examine the changes associated with BMP4 induced EMT, we treated 
the cells on the different substrates and examined cell morphology using actin 
along with E-cadherin localization (Figure 2.1B Figure 2.2C). We find that 
OvCa429 and Panc1 cells treated with BMP4 for 5 and 3 days, respectively, on 
the 8kPa showed similar actin morphology and E-cadherin localization as cells 
cultured on glass for 5 and 3 days for OvCa429 and Panc1, respectively. (Figure 
2.1B, Figure 2.2C and Figure 2.11A-B), while cells on the 0.5kPa substrates 
showed no change in actin morphology or E-cadherin localization. E- cadherin 
remained tightly localized around cell- cell junctions along with cortical actin 
(Figure 2.1B, Figure 2.2C), in contrast to on stiffer substrates where E-cadherin 
appeared more scattered and diffuse, along with actin showed significant stress 
fibers (Figure 2.11B, Figure 2.12C). To test if these changes were associated 
with rapid induction of EMT associated transcriptional factors Snail, Slug, and 
Zeb1, we treated the cells on the different substrates with BMP4 for 24 hours, 
after the cells were plated on the substrates for at least 12 hours. We find that 
each of the three cell lines upregulated a subset of the examined transcription 
factors (Snail: 11 fold, 14 fold, and 17 fold, Slug: 25 fold, 24 fold, and 10 fold for 
OvCa429, Panc1, and Py2T, respectively, and 5.5 fold and 6.5 fold for Zeb1 in 
Panc1 and Py2T, respectively) at 8Kpa (Figure 2.2D) at levels comparable to 
plastic (Figure 2.12C). Cells on soft 0.5kPa gels, altered their transcription levels 
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to significantly lesser extents, in response to BMP4, as compared to the 8kPa 
substrates (Figure 2.2D).   
 To examine if this was due to a defect in mounting a signaling response to 
BMP4 on 0.5Kpa gels, we examined if Smad1 activation was altered on the 
substrates with varying rigidities. Phosphorylation of Smad1 was determined by 
treating cells with exogenous BMP4 after allowing the cells to grow for 24 hours 
on the different substrates. No significant difference in Smad1 activation (Figure 
2.3E) was observed on the substrates with different rigidities indicating that 
change in response was not at the level of signal reception. Since no significant 
change in Smad1 phosphorylation was observed, we tested if Smad1 nuclear 
translocation in response to BMP4 was altered on 0.5kPa soft substrates. We 
examined Smad1 and the co-Smad Smad4 localization by treating the cells with 
BMP4 on the 0.5kPa and 8kPa substrates. We find that both Smad1 and Smad4 
were excluded from the nucleus in compliant gels (0.5Kpa) in all three models, 
while BMP4 induced Smad1 and Smad4 localization to the nucleus occurs 
robustly in more rigid substrates at the 1 hr time point (Figure 2.4F for Smad1 
and Figure 2.13B for Smad4) and at longer time points as well (data not shown). 
These data suggest that lower transcriptional response to BMP4 on soft 
substrates may be due to reduced nuclear Smad localization.  
  Since BMP4 can activate both Smad1 and non-Smad pathways [7], we 
confirmed that cancer EMT in response to BMP4 was largely driven by a Smad1 
mechanism in the cell lines used. We examined the effect of dorsomorphin, an 
inhibitor of the BMP receptors BMPR1A/R1B that blocks Smad1 phosphorylation 
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[36], and performed shRNA to Smad1 on BMP4 induced EMT. Dorsomorphin 
significantly reduced BMP4 induced increase in Snail and Slug transcript levels 
(Figure 2.13A) and two siRNA constructs (Figure 2.3A) (Methods) to Smad1 
significantly reduced BMP4 induced Snail and Slug transcription and suppressed 
BMP4 induced cell invasion (Figure 2.3 B,C,D). While these data do not rule out 
possible contributions of non-Smad pathway or Smad2/3 involvement [7], they 
confirm Smad1’s significant role in mediating BMP4 induced EMT in the different 
cancer cell line model systems and suggest that failure to mount a Smad1 
response on substrates of 0.5kPa rigidity may lead to a failure to mount an EMT 
response as well.  
To define the mechanistic impact of substrate rigidity on BMP4 induced 
EMT, we hypothesized a role for the mechanosensitive Yap1 [33] that besides 
being regulated by the Hippo pathway can also interact with Smad1 in a BMP 
dependent manner [23]. To test a direct role for Yap1, we used two independent 
shRNAs to Yap1 in the two human cell lines Panc1 and OvCa429 (Figure 2.5A). 
We find that BMP4 induced EMT transcription factors Snail and Slug, were 
suppressed 2.5 and 9 fold in OvCa429 and Panc1 shYap cells, respectively, 
compared to control cells (Figure 2.5B). Similarly, shYap1 reduced BMP4 
induced cell invasion in OvCa429 and Panc1 cells by 10 and 14 fold, respectively 
(Figure 2.6C,D). These data implicate Yap1 in mediating BMP4 dependent EMT 
responses. Since Yap1 can integrate multiple signals including the Hippo 
pathway [37] and matrix rigidity [33], and is required for BMP4 induced EMT 
(Figure 2.5B, Figure 2.6D), we asked if BMP4 could induce nuclear translocation 
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of Yap1 to facilitate EMT. We find that BMP4 increases and induces the nuclear 
translocation of Yap1 on rigid substrates even in cells that have cell- cell contact 
(8kPa, Figure 2.6E). However, BMP4 does not increase the amount of Yap1 in 
the nucleus on soft substrates—where BMP4 was unable to induce EMT (Figure 
2.6E). These Yap1 shRNA findings, together with a role for Smad1 in BMP4 
mediated EMT reduction, suggest a role for nuclear Yap1 in mediating Smad1 
induced EMT.  
The kinase activities of Cdk8 and Cdk19 are required for BMP4 induced EMT 
Our data strongly indicate that BMP4 induced EMT is driven by nuclear 
Smad1 and Yap1. However, Yap interaction with Smad1 and its ability to mediate 
Smad1 responses is dependent on the activity of the mediator kinase CDK8 in 
the nucleus that phosphorylates the Smad1 linker region resulting in recruitment 
of Yap1 [23]. Therefore, we tested a role for CDK8 in BMP4 induced EMT. To do 
this, we used the specific ATP competitive inhibitor of CDK8 and its isoform 
CDK19, Senexin B [38]. Inhibition of the kinase activity of the twin kinases 
CDK8/19 using Senexin B robustly suppressed BMP4 induced increase in the 
transcription factor Slug in OvCa429, Panc1, and Py2T EMT models and Snail 
and Zeb1 in Panc1 and Py2T cells without significantly altering baseline 
transcript levels (Figure 2.7A). Senexin B also lead to a suppression of BMP4 
induced invasion in all three cell lines (Figure 2.8C,D and Figure 2.14A). 
Moreover this suppression was dose dependent (Figure 2.14 3A). Since our 
observation on substrates with different rigidities suggested a role for nuclear 
Yap1 in BMP4 induced EMT, and CDK8 dependent Smad1 linker 
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phosphorylation has been shown to be required for Yap interaction with Smad1 
in the nucleus [23], we examined if blocking the kinase activity of CDK8/19 with 
Senexin B dampened BMP4 induced Yap nuclear translocation. Indeed, Senexin 
B treatment dampened Yap1 nuclear localization in response to BMP4 albeit to 
different extents in Py2T, Panc1, and OvCa429 cells (Figure 2.8B). These results 
demonstrate that the kinase activities of CDK8/19 that link Yap1 to Smad1 may 
be necessary for BMP4 induced EMT likely through the recruitment of Yap1 for 
mediating BMP4 induced EMT.  
Cdk8/Cdk19 are required for EMT. 
Since Senexin B targets the kinase activity of both CDK8 and CDK19, we 
asked if the effects of Senexin B were primarily due to CDK8, or if CDK19 could 
compensate for CDK8. To test the separate roles of CDK8 and CDK19, we 
reduced the expression of each CDK8 and CDK19 (Figure 2.9A) using 2 
independent shRNA’s for CDK8 and CDK19 (shRNA 1 to the coding region and 
shRNA2 to the 3’ UTR region) were used in the studies. Reducing the expression 
of CDK8 and CDK19 individually reduced BMP4 induced Smad1 linker 
phosphorylation (Figure 2.9B) suggesting that both CDK8 and CDK19 could 
compensate for each other’s loss. Consistent with the effects of Senexin B on 
reduced nuclear translocation of Yap1 in response to BMP4, reducing the 
expression of either CDK8 or CDK19 was able to suppress BMP4 induced Yap1 
nuclear localization (Figure 2.9C) either due to alterations in retention of either 
Smad1 or Yap1 as previously proposed [23]. We next examined the effect of 
shRNA to Cdk8 and Cdk19 on BMP4 mediated increases in EMT transcriptional 
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factors Snail and Slug. We find that shRNA to CDK8 and CDK19 resulted in a 
suppression of BMP4 induced Snail and Slug in both Panc1 and OvC429 cells 
(Figure 2.9C, Figure 2.14B) (Figure 2.10D Panc1: shCdk8 1.5 and 3 fold, 
shCdk19 2.5 and 1.5 fold, Snail and Slug, respectively. Figure 2.14B OvCa429: 
shCdk8 2 fold and 2 fold, shCdk19 N.S. and 2 fold, Snail and Slug, respectively). 
These data indicate that while Cdk8 and Cdk19 have overlapping functions in 
mediating Smad1 linker phosphorylation (Figure 2.9B), they also have distinct 
functions in regulating transcription of individual genes. Finally, to examine if 
reducing Cdk8 and Cdk19 expression also impact BMP4 induced invasion in the 
different EMT models, we examined EMT induced invasion in OvCa429 and 
Panc1 cells. We find that while loss of Cdk8 did not affect baseline invasion 
(Figure 2.10F), shCdk8, reduced BMP4 induced invasion by 2 fold in both 
OvCa429 and Panc1 cells and shCdk19 reduced BMP4 induced invasion by 4 
fold and 3 fold in OvCa429 and Panc1, respectively.  
Cdk8 and Cdk19 expression correlate with EMT genes in ovarian cancer  
Given that our in vitro studies indicate that CDK8 and CDK19 expression 
regulated EMT in ovarian cancer cell lines, we next assessed whether the 
expression of these genes correlated with common EMT markers in human high 
grade serous ovarian tumors. To address this question we examined RNAseq 
data from 283 high grade serous ovarian tumors (Data Not Shown) from the 
Cancer Genome Atlas (TCGA) project [39]. We first confirmed that positive 
correlations (Pearson) existed between up-regulated EMT markers. We found 
that SNAI1, SNAI2, TWIST1, TWIST2, ZEB1, and ZEB2 each had a significant 
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positive correlation, ranging from 0.38 to 0.78, with the expression of each other 
EMT marker (data not shown). We further confirmed the significant negative 
correlation between CDH1, expression of which is lost during EMT, and SNAI2, 
TWIST1 and ZEB1; SNAI1, ZEB2, and TWIST2 were negatively correlated but 
only trended towards significance. Consistent with our in vitro results, expression 
of neither CDK8 nor CDK19 was negatively correlated with CDH1. However, 
CDK8 expression had a significant positive correlation (Pearson Correlation: 0.14 
– 0.24) with SNAI1 (p=5.3E-04), SNAI2 (p=5.2E-04), ZEB1 (p=0.0051), TWIST1 
(p=0.0173), and TWIST2 (p=5.1E-05) while CDK19 had a significant positive 
correlation (Pearson Correlation: 0.16 - 0.22) with ZEB1 (p=2.0E-04) and 
TWIST1 (p=0.0089). Coupled with our in vitro data, these results suggest that 
CDK8, and to a lesser extend CDK19, expression is significantly associated with 
EMT.
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Figure 2.1 BMP4 Induced EMT is Suppressed 
on Compliant Substrates. (A) Phase contrast 
images of cells plated on soft (0.5kPa) and rigid 
(8kPa) fibronectin coated polyacrylamide (PA) 
hydrogels treated with BMP4 (10nM) for 5, 3, and 7 
days, respectively. (B-C) Immunofluorescence 
images of OvCa429 and Panc1 cells plated on soft 
(0.5kPa) and rigid (8kPa) fibronectin coated PA 
hydrogels treated with BMP4 for 5 days and 3 
days, respectively, followed by immunostaining 
with phalloidin for actin (B) and anti-e-cadherin. 	
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Figure 2.2 (Figure 2.1 continued) C) Scale bars 20µm. (D) 
Real time quantitative PCR showing the levels of the 
transcription factors Slug, Snail, and Zeb1 inOvCa429, Panc1, 
and Py2T cells plated on soft (0.5kPa) and rigid (8kPa) PA 
hydrogels treated with BMP4 for 5 days, 3 days, and 2 days, 
respectively. Values are normalized to their untreated control 
(black line). Graphs are representative of two independent 
experiments done in triplicate.*p<0.05, **p<0.01, *** p<0.001.	
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Figure 2.3 BMP4 Induced EMT is Driven by Smad1 (A-B) Real time 
quantitative PCR showing expression fold change of Smad1 (A) and fold 
change in transcript levels, relative to the untreated control, for Slug, Snail, 
and E-cadherin (B) in OvCa429 and Panc1 cells expressing shSmad1 or 
shScr after being treated with BMP4 (10nM) for 24hrs and 12 hours, 
respectively. Values are normalized to their untreated control (Black horizontal 
bars). Error bars represent the standard error of the mean. *p<0.05, **p<0.01. 
(C-D) OvCa429 and Panc1 cells expressing shSmad1 or shScr cells were 
treated with BMP4 (10nM), then immediately plated in transwell chambers 
coated with MatriGel (400µg/mL). Cells were allowed to invade for 18 hours. 
Images (C) are cells on the underside of the chamber taken at x10. Images 
are representative of two independent experiments done in triplicate. 
Graphical representation of the number of invading cells from four 
independent fields. Error bars represent the standard error of the mean. *** 
p<0.001. (E) Time course of Smad1/5 phosphorylation in Panc1 cell lines 
treated with BMP4 (10nM) plated on soft (0.5kPa) and rigid (8kPa) fibronectin 
coated polyacrylamide (PA) hydrogels. Lysates were analyzed by 
immunoblotting with indicated antibodies.		
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Figure 2.4 Figure 2.3 Continued. (F) 
Immunofluorescence images of OvCa429, 
Panc1, and Py2T cells plated on soft (0.5kPa) 
and rigid (8kPa) fibronectin coated PA 
hydrogels treated with BMP4 (10nM) for 1 hour, 
respectively, followed by immunostaining with 
anti-Smad1. Overlay images are shown with the 
nuclear stain 4’, 6-diamidino-2-phenylindole. 
Scale bar = 20µm.	
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Figure 2.5 Yap1 Enhances BMP4 Induced EMT. (A-B) Real 
time quantitative PCR showing Yap1 fold changes in the 
knockdown cell lines as indicated (A) and the fold change of the 
transcription factors Snail and Slug in OvCa429 and Panc1 cells 
expressing shYap or shPlko1 after being treated with BMP4 
(10nM) for 24hrs and 12hrs, respectively (B). Values are 
normalized to their untreated control (Black horizontal line) 
*p<0.05, **p<0.01, *** p<0.001.	
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Figure 2.6 Figure 2.5 continued. (C-D) OvCa429 and Panc1 cells 
expressing shYap or shPlko1 were treated with BMP4 (10nM), then 
immediately plated in transwell chambers coated with MatriGel 
(400µg/mL). Cells were allowed to invade for 18 hours. (C) Images are 
cells on the underside of the chamber taken at x10. Graphical 
representation of the number of invading cells from four independent 
fields. Error bars represent the standard error of the mean (E) 
Immunofluorescence images of OvCa429, Panc1, and Py2T cells 
plated on soft (0.5kPa) and rigid (8kPa) fibronectin coated PA hydrogels 
treated with BMP4 (10nM) for 1 hour followed by immunostaining with 
anti-Yap. Scale bar = 20µm.  	
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Figure 2.7 The Kinase Activity of Cdk8/19 Enhances BMP4 Induced 
EMT. (A) Real time quantitative PCR showing the fold change in levels 
of the transcription factors Snail, Slug, and Zeb1 inOvCa429, Panc1, 
and Py2T cells pre-treated with SnxB (5µM) for 30 minutes, then 
treated with BMP4 (10nM) for 24hrs, 12hrs, and 48hrs, respectively. 
Graphs are representative of two independent experiments done in 
triplicate. Error bars represent the standard error of the mean. *p<0.05, 
**p<0.01, *** p<0.001.	
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Figure 2.8 Figure 2.7 continued. (B) Immunofluorescence images 
of OvCa429, Panc1, and Py2T cells pre-treated for 30 minutes with 
SnxB (5µM), then treated with BMP4 (10nM) for 24 hours followed 
by immunostaining with Yap. Scale bars = 20µm (C) OvCa429 and 
Panc1 cells were pre-treated with SnxB (5µM) for 30 minutes, then 
treated with BMP4 (10nM), and then immediately plated in transwell 
chambers coated with MatriGel (400µg/mL). Cells were allowed to 
invade for 18 hours. Graphical representation of the number of 
invading cells from four independent fields. Error bars represent the 
standard error of the mean.  	
B	 C	
D	
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Figure 2.9 Cdk8/19 Enhance BMP4 EMT and Exhibit Differential 
Effects. (A) Real time quantitative PCR showing the levels of Cdk8 and 
Cdk19 in OvCa429 and Panc1 cells. (B) OvCa429 and Panc1 cells with 
stable shRNA Cdk8 and Cdk19 knockdown were treated with BMP4 
(10nM) for 1 hour, analyzed by immunoblotting with the indicated 
antibodies. (C) Immunofluorescence images of OvCa429 and Panc1 cells 
expressing shScr, shplko.1, shCdk8, or shCdk19 treated with BMP4 for 24 
hours, followed by immunostaining with anti- Yap. Scale bar = 20µm.	
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Figure 2.10 Figure 2.9 Continued (D) Real time quantitative PCR 
showing the levels of the transcription factors Snail and Slug in Panc1 
cells expressing shPlko.1, shCdk8, or shCdk19 treated with BMP4 
(10nM) for 24 hours. Graphs are representative of two independent 
experiments done in triplicate. Error bars represent the standard error 
of the mean. *p<0.05, **p<0.01, *** p<0.001.  (E-F) OvCa429 and 
Panc1 cells were treated with BMP4 (10nM), then immediately plated in 
transwell chambers coated with MatriGel (400µg/mL). Cells were 
allowed to invade for 18 hours. (E) Images are cells on the underside of 
the chamber taken at x10. Images are representative of two 
independent experiments done in triplicate. (F) Graphical 
representation of the number of invading cells from four independent 
fields. Error bars represent the standard error of the mean. 	
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Figure 2.11. Supplementary Figure 1. (A) OvCa429 
and Panc1 cells treated with BMP4 (10nM) for 
indicated times. Lysates were analyzed by 
immunoblotting with indicated antibodies. (B) 
OvCa429 and Panc1 cells treated with BMP4 (10nM) 
for 5 and 3 days, respectively, followed by 
immunostaining with anti-E-cadherin or phalloidin for 
actin. Scale bars = 20µm. Done in triplicate. Error bars 
represent the standard error of the mean.	
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Figure 2.12 (Figure 2.11 Supplementary Fig 1 continued): (C) Real 
time quantitative PCR showing the levels of the transcription factors 
Snail, Slug, and E-cadherin in OvCa429 and Panc1 cells treated with 
BMP4 (10nM) for 24 and 12 hours, respectively. Graphs are 
representative of two independent experiments (D-E) OvCa429 and 
Panc1 cells were treated with BMP4 (10nM), then immediately plated in 
transwell chambers coated with MatriGel (1mg/mL). Cells were allowed 
to invade for 2 days. Images (B) are cells on the underside of the 
chamber taken at x10. Images are representative of two independent 
experiments done in triplicate. Graphical representation of the number 
of invading cells from four independent fields. Error bars represent the 
standard error of the mean.  	
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Figure 2.13. Supplementary Figure 2 (A) Real time quantitative 
PCR showing the levels of the transcription factors Snail and 
Slug in OvCa429 and Panc1 cells pre-treated with dorsomorphin 
(5µM) for 30 minutes, then treated with BMP4 (10nM) for 24 and 
12 hours, respectively. (B) Immunofluorescence images of 
OvCa429 and Panc1 cells plated on soft (0.5kPa) and rigid 
(8kPa) fibronectin coated PA hydrogels treated with BMP4 
(10nM) for 1 hour, respectively, followed by immunostaining with 
anti-Smad4. Overlay images are shown with the nuclear stain 
4’,6-diamidino-2-phenylindole. 	
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Figure 2.14. Supplementary Figure 3 (A) OvCa429 and 
Panc1 cells were pre-treated with SnxB with increasing 
concentrations from 250nM, 500nM, 1µM, and 5µM for 30 
minutes, then treated with BMP4 (10nM), and then 
immediately plated in transwell chambers coated with 
MatriGel (400µg/mL). Cells were allowed to invade for 18 
hours. Error bars represent the standard error of the mean. 
(B) Real time quantitative PCR showing the levels of the 
transcription factors Snail and Slug in OvCa429 cells 
expressing shScr, shCdk8, or shCdk19 treated with BMP4 
(10nM) for 24 hours. Graphs are representative of two 
independent experiments done in triplicate. Error bars 
represent the standard error of the mean. 	
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Chapter 3 
Discussion 
The role of BMP4 in the progression of cancer has been conflicting given 
that it has been shown to increase cell invasiveness, migration, and metastasis in 
some cancers [13-15, 40], however, has been shown to suppress growth and 
found in lower levels in other cancers [16, 41]. Determining the signaling pathway 
and specific factors involved in BMP4 induced EMT could help identify under 
what conditions BMP4 acts as a tumor suppressor or promoter. Previous studies 
have shown that BMP4 is able to signal through Smad1 and Smad2 [7]. Our 
studies confirm that BMP4 induced Smad1 activation prompts EMT in ovarian, 
pancreatic, and breast cancer cell models (Figure 2.3B-D, Fig 2.13). The present 
study shows the requirement of the transcriptional regulators Cdk8/19, as well as 
the transcriptional co-activator Yap1 in Smad1 dependent BMP4 induced EMT in 
ovarian, pancreatic, and breast cancer cell line models. We also find that Yap1, 
Cdk8, and Cdk19 are each responsible for the increases in the EMT associated 
transcription factors Snail and Slug along with the increase in cell invasion 
associated with BMP4 signaling. Consistent with previous studies, our data show 
that Cdk8 is necessary for the linker phosphorylation of Smad1 [23], along with 
its isoform Cdk19. The ability of both Cdk8 and Cdk19 to suppress BMP4 
induced Snail, Slug, invasion, Yap1 nuclear retention, and Smad1 linker 
phosphorylation indicate not only that they are important in the
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regulation of BMP4 induced EMT, but they may be able to compensate for one 
another.  
Our study shows for the first time the use of Senexin B, the specific small 
molecule inhibitor of Cdk8 and Cdk19, in the involvement of suppressing 
transcriptional activation of EMT transcription factors Snail and Slug with robust 
effects on suppressing cell invasion, thus further confirming the role of Cdk8 and 
Cdk19 involvement in BMP4 induced EMT. These findings on the effects of 
Senexin B also have broader implications for the use of Senexin B as a potential 
therapeutic strategy for suppressing metastasis. Cdk8 has been shown to be an 
oncogene and leads to cancer progression in a variety of cancers including 
pancreatic, colon, and breast cancers and melanoma [18-22]. In addition to the 
BMP4/Smad1 signaling pathway, Cdk8 has also been shown to be involved in 
other signaling pathways, including Wnt/β-catenin, Tgf-β, and Notch [18, 23, 42]. 
The diverse role of Cdk8 indicates that Senexin B may be able to be used as a 
selective approach to improve cancer treatment. 
 We find that softer substrates dampen the effects of BMP4 on the EMT 
associated transcription factors, Snail and Slug, along with inhibiting E-cadherin 
dislocation from the junctions. This is similar to previous studies on matrix rigidity 
with Tgfβ−1, where decreased matrix rigidity reduced the levels of Tgfβ−1 
induced Snail expression, as well as increasing E-cadherin localization along the 
cell junctions [34]. Since BMP4 induced EMT seems to be primarily driven by 
Smad1 (Figure 2B-D), this decrease in EMT response could be due to the 
exclusion of Smad1 and Smad4 from the nucleus.  Prior studies on matrix 
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stiffness have shown that a decreased rigidity resulted in Yap exclusion from the 
nucleus [33]. In addition to Yap exclusion from the nucleus with softer substrates, 
we found that BMP4 is unable to override the mechanical control on Yap1, as 
Yap1 remains excluded from the nucleus on soft substrates. Cdk8/19, however, 
remained localized in the nucleus regardless of matrix rigidity (data not shown). 
Because matrix rigidity reduced the effects of EMT, while inhibiting Smad1 and 
Yap1 activity, this data could suggest that Smad1 and Yap1 are necessary for 
the activity of Cdk8/19 during BMP4 induced EMT. The particular mechanism by 
which Cdk8/19, Yap1, and Smad1 interact to drive BMP4 induced EMT had yet 
to be established. Future studies to examine the interplay among these factors 
will help elucidate their roles in the regulation of EMT by Cdk8/19. 
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Chapter 4 
Materials and Methods 
Cell Lines and Culture Conditions 
OvCa429 cells were obtained from Duke Gynecology/Oncology Bank, Panc1 
cells were from ATCC, and Py2T cells were a kind gift from Gerhard Christofori 
(University of Basel). Panc1 and Py2T cells were cultured in DMEM containing L-
glutamine, 10% fetal bovine serum (FBS), and 100 U of penicillin-streptomycin. 
OvCa429 cells were cultured in RPMI containing L-glutamine, 10% fetal bovine 
serum (FBS), and 100 U of penicillin-streptomycin.  
Softwells 
For rigidity experiments, cells were plated on 0.5kPa (soft) or 8kPa (rigid) 
substrates (Matrigen, Softslip 12 well and Softwell 6 well) that were coated with 
10ug/mL fibronectin (Cultrex® #3420-001-01) in 1X PBS for one hour. All cells 
were allowed to sit on substrates for at least 12 hours before BMP4 treatment.  
For Smad1 (1 hour treatment) and Yap1 (24 hour treatment) localization 
experiments on Softslip 12 well, 50000 cells were plated on 8kPa substrates and 
100000 cells were plated on 0.5kPa substrates. For E-cadherin and actin 
staining, plated 40000 cells on 8kPa and 80000 cells on 0.5kPa, 30000 cells on 
8kPa and 60000 cells on 0.5kPa, and 10000 cells on 8kPa and 40000 cells on 
0.5kPa for Panc1(3 day treatment), OvCa429 (5 day treatment with re-treatment 
at day 3), and Py2T cells(7 day treatment with re-treatment at day 4), 
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respectively. For time course experiments on Softwell 6 well, 200000 cells were 
plated on 8kPa substrates and 300000 cells were plated on 0.5kPa substrates. 
For qPCR experiments on Softwell 6 well, plated 50000 on 8kPa and 200000 
cells on 0.5kPa for OvCa429 cells (5 day treatment with re-treatment at day 3), 
80000 on 8kPa and 200000 cells on 0.5kPa for Panc1 cells (3 day treatment), 
and 70000 cells on 8kPa and 200000 cells on 0.5kPa for Py2T cells (2 day 
treatment).  
Antibodies, Reagents, Plasmids, and Lentiviral Infections 
Antibody E-cadherin (BD Biosciences #610181), B-Actin (Sigma #A2228) was 
from Sigma. pSmad1 Ser206 (#5753), pSmad1/5/8 (#9511), Smad1 (#6944), and 
Smad4 (#9515) antibodies were from Cell Signaling.  Senexin B was from Senex. 
For Smad1 knockdown, OvCa429 and Panc1 cells were infected with 100MOI 
siRNA adenovirus construct, generously provided by Maria Trojanowska. 
Lipofectamine 2000 (Life Technologies #11668019). Constructs with the shRNA 
to Yap was obtained from Sigma with the following sequences:
Yap:0000107265: 
CCGGCCCAGTTAAATGTTCACCAATCTCGAGATTGGTGAACATTTAACTGGG
TTTTTG and 
Yap:0000107268:CCGGGACCAATAGCTCAGATCCTTTCTCGAGAAAGGATCT 
GAGCTATTGGTCTTTTTG. For Yap knockdown, OvCa429 and Panc1 cells 
were infected at a 1:8 ratio of the Yap shRNA lentiviral construct. The target 
sequences for Cdk8 shRNA were CCTCTGGCATATAATCAAGTT, and for 
Cdk19 was GCTTGTAGAGAGATTGCACTT. For Cdk8 and Cdk19 knockdown, 
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OvCa429 and Panc1 cells were infected at a 1:4 ratio of the Cdk8 and Cdk19 
shRNA lentiviral construct. OvCa429 and Panc1 cells were selected in puromycin 
at 3µg and 5µg, respectively. All shRNA lentiviral constructs were generously 
provided by Serena Altilia (University of South Carolina). The knockdown was 
confirmed by qPCR (sequences in Table 1).  
Quantitative Polymerase Chain Reaction 
Panc1, OvCa429, and Py2T cells were treated for 12, 24, and 48 hours, 
respectively. In experiments where SenexinB was used, cells were pre-treated 
with SenexinB for 30 minutes.  Total RNA was isolated from cells using Trizol 
reagent (Invitrogen, Carlsbad, CA). 1ug of RNA was reverse transcribed to cDNA 
using 5x iScript Reverse Transcription Supermix (Bio-Rad #1708840) and the 
Sso Advanced Universal SYBR Green Supermix (Bio-Rad #1725271). qRT-PCR 
primer sequences are listed in Table 1.   
MatriGel Invasion Assays 
Invasion assays were performed using 24-well transwells (Greiner Bio-One; 
ThinCertsTM, 24 well 8.0um) coated with 400ug/ml MatriGel (BD Biosciences 
#3248404). Cells (50,000) in serum free media were plated in upper chamber, 
and allowed to invade for 18 hours toward serum media in lower chamber. Filters 
were stained with Three Step Stain (Richard-Allan Scientific). The filters were 
removed and mounted onto glass slides. Cells on the filter were counted using 
an Olympus DP21 microscope at x10 magnification.  
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Immunofluorescence 
In experiments where SenexinB was used, cells were pre-treated with SenexinB 
for 30 minutes. Cells were fixed in 4% paraformaldehyde, permeabilized in 0.1% 
TX-100, and blocked with 1% BSA PBS. Cells were incubated in primary 
antibody (1:200) for an hour, followed by incubation with Alexa Fluor 488 or 594 
second antibody (LifeTechnologies). After washing, cells were stained with 4’6-
diamidino-2-phenylindole (Roche). Imaging was performed using an Olympus 
IX81 motorized inverted microscope. Imaging was performed using Imaging on 
substrates was performed using a Zeiss LSM700 confocal microscope. 
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Appendix A 
OvCa429 Data
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Figure A.1: Effect of BMP on Transcript Levels & Migration (A) Effect of 
BMP4 on EMT Transcript Levels. Expt 2-11. (B) Effect of BMP4 on 
EMT Transcript Levels Time Course. Expt 2-34. (C) Effect of BMP4 on 
migration. Expt 2-17.  
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Figure A.2: Effects of BMP on Smad Signaling (A) Effect of BMP2 on 
Integrin Levels. Expt 2-1. (B) Role of Alk3/6 & Alk5/7 on BMP4 Induced 
EMT. Expt 2-41. (C) Effect of BMP4 on Smad Signaling. Expt 2-14.  
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Figure A.3: Role of Alk3/6 & Alk5/7 on BMP4 Induced EMT Transcript 
Levels. Expt 2-39.  
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Figure A.4: Effects of Blebbistatin and Y27632 on Yap Localization. Expt. 2-
28.  
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Figure A.5: Effects of Matrix Rigidity on BMP4 Induced EMT 1. 
(A) Expt. 2-24. (B-C) Expt 2-13. (D) Expt 2-16.  
		 43 
Figure A.6: Effects of Matrix Rigidity on BMP4 
Induced EMT 2. (A) Expt.3-8 (B) Expt 2-24. (C) 
Expt. 2-27  
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Figure A.7: Effects of Matrix Rigidity on BMP4 Induced EMT 
and Apoptosis. (A-B) Expt. 2-22   
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Figure A.8: Effect of Matrix Rigidity on BMP Induced EMT/Receptor 
Levels (A) Effects of Matrix Rigidity on EMT Transcript Levels (Time 
Course) Expt 3-15(B) Effects of Matrix Rigidity on Alk3/6 Receptor 
Levels. Expt 3.12 
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Figure A.9: Effect of Yap5SA on BMP Induced EMT (A-B) Effect of 
Yap5SA on BMP4 EMT. Expt 4-8. (C) Effect of Matrix Rigidity and Yap 
5SA on BMP4 EMT. Expt 4-19 
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Figure A.10: Effects of SnxB on BMP4 Induced EMT (A) E-cadherin (B) 
Actin (A-B) Expt 3-19 
Actin 
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Figure A.11: Effects of shCdk8 and shCdk19 on BMP4 Induced 
EMT. Expt. 4-5.  
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Figure A.12: Effect of Wnt3a and Tgf-β1/2 on 
EMT. Expt 2-42.   
		 50	
  
Figure A.13: Effects of R3 and Wnt3a on EMT. (A-C) Transcript 
Levels. Expt 3-11. (D) Effects of R3 and deltaGAG on Wnt3a 
Invasion. Expt 3-26.  
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Appendix B  
Panc1 Data 
  
		 52 
Figure B.1: Effects of BMP on Migration (A) Effects of BMP4 on EMT over 
time. Expt 2-34. (B-C) Effects of BMP4 on migration. Expt 2-12.  
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Figure B.2: Role of BMP on Integrins and Smad Signaling (A) Effects of 
BMP2 on Integrin Levels. Expt 2-1. (B-C) Role of Alk3/6 and Alk5/7 on 
BMP4 Induced EMT (B) Western analysis. Expt 2-41 (C) qPCR. Expt 2-39. 
(D) Effect of BMP4 on Smad Signaling. Expt 2-14.  
		 54 
Figure B.3: Effect of Blebbistatin and Y27632 on Yap Localization 
		 55 
Figure B.4: Effects of Matrix Rigidity on BMP4 Induced EMT 1 (A-B, D-E). (A-
B) Expt 2-13. (D) Expt. 2-16. (E) Expt 2-24. (B) Effects of Matrix Rigidity on 
BMP2 Induced EMT. Expt 2-3.  
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Figure B.5: Effects of Matrix Rigidity on BMP4 Induced EMT 2 (A-C), 
Apoptosis, and Autophagy (C-D). (A) Expt 2-24. (B) Expt 3-8. (C-D) Expt. 
3-9.  
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Figure B.6: Effects of Matrix Rigidity on BMP4 induced EMT 
3. (A-B) (Time Course). Expt 3-5.  
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Figure B.7: Effect of SnxB on BMP4 Induced EMT IF. (A) Actin (B) E-cadherin 
Expt. 3-19 
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Figure B.8: Effect of BMP4, Snx, shCdk8, and shCdk9 on Cell Proliferation (A) 
Graphed by Treatment (B) Graphed by Cell Line. Expt 3-25 
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Figure B.9: Effect of shCdk8 (kinase dead) on BMP4 Induced EMT. (A-
B) Expt. 3-4. 
		 61 
Figure B.10: Effects of Wnt3a on BMP4/Tgfβ-1 
Induced EMT. (A-C) Expt 2-42.  
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Figure B.11: Effects of Matrix Rigidity on Cell Stiffness. On 
server.  
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Appendix C 
CT26 Data
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Figure C.1: Effect of SnxB on CT26 Cell Invasion. Expt S-22.  
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Figure C.2: Effects of SnxB on BMP4 
Induced EMT. Expt. S-23.  
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Figure C.3: Effects of SnxB and shCdk8 on CT26 Cell Migration 
(with repeat). Expt. S-21.  
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Figure C.4: Effects of SnxB, shCdk8, 
shSmad4, & shB-catenin on Invasion 1. 
shCdk8 (A), shSmad4 (B), shBcatenin (C), 
and shStat1 (D) on BMP4 Induced EMT. 
Expts. S-27 (A), S-29(B,D), and S-28 (C) 
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Figure C.5: Effects of SnxB, shCdk8, shSmad4, & 
shB-catenin on Invasion 2. shCdk8 (A), shSmad4 
(B), and shBcatenin (C) on BMP4 Induced EMT. 
Expt S-31. 
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Figure C.6: Effects of SnxB, shCdk8, shSmad4, & shB-
catenin on Invasion 3. shCdk8 (A), shSmad4 (B), and 
shBcatenin (C) on BMP4 Induced EMT. Expt S-32.  	
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Appendix D 
Py2T Data
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Figure D.1: Effects of SnxB on Tgf-β1 
Induced Invasion. Expt. S-18.  
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Figure D.2: Effects of SnxB on Tgf−β1 and BMP4 Induced EMT. Expt. 2-
34. 
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Appendix E 
Miscellaneous Data
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Figure E.1: Effects 
of BMP4 on EMT in 
OvCa4 Cells 
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Figure E.2: Effects of BMP4 on Smad Signaling 
in OvCa433 Cells.  
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Figure E.3: Effects of SnxB on Tgf-β Induced 
EMT in NMuMg Cells.  
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Figure E.4: Effects of SnxB on Tgf-β 
Induced EMT in NMuMg Cells. Expt S-11.  
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Figure E.5: Effects of SnxB on Tgf-β Induced FN Invasion in NMuMg Cells. 
Expt. S-17.  
